Clinical Trial Aimed At Preventing Wet AMD Approved By FDA Starts Enrollment At SCDRC

Clinical Trial Aimed At Preventing Wet AMD Approved By FDA Starts Enrollment At SCDRC

Posted on: July 29, 2014

This is a multicenter, prospectively randomized, masked and controlled, interventional investigator sponsored phase I/II study of subjects with high-risk nonexudative age-related macular degeneration (AMD) treated with intravitreal ranibizumab quarterly for prophylaxis of conversion to exudative age-related macular degeneration. The objective of this study is to investigate the safety and efficacy of prophylactic anti-vascular endothelial growth […]

Read More